Biotron
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WABiotron Limited (BIT) is a clinical stage Australian Biotechnology Company based in Sydney, Australia. The company is involved in the development and commercialization of a novel small molecule approach that has the potential to treat several serious viral diseases. The technology targets viroporin proteins which enables the pathogenicity of several viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and Respiratory Syncytial Virus (RSV). The company has operations in Australia.
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1808th | Biotron | -79% | -22% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Biotron | $1.6m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| ECM DEAL: New deal has been added | 03 Mar 2023 |
| REMUNERATION UPDATE: Michael Hoy, Non-Executive Director, Non-Executive Chairman | 03 Nov 2020 |
| REMUNERATION UPDATE: Robert Thomas, Non-Executive Director | 03 Nov 2020 |
| REMUNERATION UPDATE: Susan Pond, Non-Executive Director | 03 Nov 2020 |
| REMUNERATION UPDATE: Michelle Miller, Managing Director | 03 Nov 2020 |
| REMUNERATION UPDATE: Peter Nightingale, Company Secretary | 03 Nov 2020 |
| NEW ROLE: Stephen A Locarnini, Non-Executive Director | 03 Nov 2020 |
